In Vitro Synergy of Colistin Combinations against Colistin-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates

被引:99
|
作者
Vidaillac, Celine [1 ,2 ]
Benichou, Lothaire [1 ]
Duval, Raphael E. [1 ,2 ]
机构
[1] Univ Lorraine, SRSMC, CNRS, UMR 7565, Nancy, France
[2] Univ Lorraine, ABC Platform, Nancy, France
关键词
MULTIPLE INOCULA; STRAINS; INFECTION; BACTERIA; MODEL;
D O I
10.1128/AAC.05996-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Colistin resistance, although uncommon, is increasingly being reported among Gram-negative clinical pathogens, and an understanding of its impact on the activity of antimicrobials is now evolving. We evaluated the potential for synergy of colistin plus trimethoprim, trimethoprim-sulfamethoxazole (1/19 ratio), or vancomycin against 12 isolates of Acinetobacter baumannii (n = 4), Pseudomonas aeruginosa (n = 4), and Klebsiella pneumoniae (n = 4). The strains included six multidrug-resistant clinical isolates, K. pneumoniae ATCC 700603, A. baumannii ATCC 19606, P. aeruginosa ATCC 27853, and their colistin-resistant derivatives (KPm1, ABm1, and PAm1, respectively). Antimicrobial susceptibilities were assessed by broth microdilution and population analysis profiles. The potential for synergy of colistin combinations was evaluated using a checkerboard assay, as well as static time-kill experiments at 0.5 x and 0.25 x MIC. The MIC ranges of vancomycin, trimethoprim, and trimethoprim-sulfamethoxazole (1/19) were >= 128, 4 to >= 128, and 2/38 to >128/2,432 mu g/ml, respectively. Colistin resistance demonstrated little impact on vancomycin, trimethoprim, or trimethoprim-sulfamethoxazole MIC values. Isolates with subpopulations heterogeneously resistant to colistin were observed to various degrees in all tested isolates. In time-kill assays, all tested combinations were synergistic against KPm1 at 0.25 x MIC and 0.5 x MIC and ABm1 and PAm1 at 0.5 x MIC. In contrast, none of the tested combinations demonstrated synergy against any colistin-susceptible P. aeruginosa isolates and clinical strains of K. pneumoniae isolates. Only colistin plus trimethoprim or trimethoprim-sulfamethoxazole was synergistic and bactericidal at 0.5 x MIC against K. pneumoniae ATCC 700603. Colistin resistance seems to promote the in vitro activity of unconventional colistin combinations. Additional experiments are warranted to understand the clinical significance of these observations.
引用
收藏
页码:4856 / 4861
页数:6
相关论文
共 50 条
  • [1] In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates
    Hong, Duck Jin
    Kim, Jung Ok
    Lee, Hyukmin
    Yoon, Eun-Jeong
    Jeong, Seok Hoon
    Yong, Dongeun
    Lee, Kyungwon
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2016, 86 (02) : 184 - 189
  • [2] In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
    Mantzana, Paraskevi
    Protonotariou, Efthymia
    Kassomenaki, Angeliki
    Meletis, Georgios
    Tychala, Areti
    Keskilidou, Eirini
    Arhonti, Maria
    Katsanou, Charikleia
    Daviti, Aikaterini
    Vasilaki, Olga
    Kagkalou, Georgia
    Skoura, Lemonia
    [J]. ANTIBIOTICS-BASEL, 2023, 12 (01):
  • [3] In vitro synergism of combinations of colistin with selected antibiotics against colistin-resistant Acinetobacter baumannii
    Percin, Duygu
    Akyol, Selcan
    Kalin, Gamze
    [J]. GMS HYGIENE AND INFECTION CONTROL, 2014, 9 (02):
  • [4] Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
    Ayerbe-Algaba, Rafael
    Luisa Gil-Marques, Maria
    Enrique Jimenez-Mejias, Manuel
    Sanchez-Encinales, Viviana
    Parra-Millan, Raquel
    Eugenia Pachon-Ibanez, Maria
    Pachon, Jeronimo
    Smani, Younes
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2018, 8
  • [5] IN VITRO ANTIBIOTIC SYNERGY COLISTIN-RESISTANT KLEBSIELLA PNEUMONIAE
    Prawang, Abhisit
    Santimaleeworagun, Wichai
    Changpradub, Dhitiwat
    Thunyaharn, Sudaluck
    Puttilerpong, Chankit
    [J]. SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2019, 50 (04) : 703 - 707
  • [6] Eugenol works synergistically with colistin against colistin-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae isolates by enhancing membrane permeability
    Kong, Jingchun
    Wang, Yue
    Yao, Zhuocheng
    Lin, Yishuai
    Zhang, Yi
    Han, Yijia
    Zhou, Tieli
    Ye, Jianzhong
    Cao, Jianming
    [J]. MICROBIOLOGY SPECTRUM, 2023,
  • [7] Eugenol works synergistically with colistin against colistin-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae isolates by enhancing membrane permeability
    Kong, Jingchun
    Wang, Yue
    Yao, Zhuocheng
    Lin, Yishuai
    Zhang, Yi
    Han, Yijia
    Zhou, Tieli
    Ye, Jianzhong
    Cao, Jianming
    [J]. MICROBIOLOGY SPECTRUM, 2023, 11 (05):
  • [8] Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates
    Choi, Myung-Jin
    Ko, Kwan Soo
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (01) : 275 - 277
  • [9] CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates
    Vila-Farres, Xavier
    Callarisa, Anna Elena
    Gu, Xiaobo
    Savage, Paul B.
    Giralt, Ernest
    Vila, Jordi
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 46 (05) : 568 - 571
  • [10] SYNERGISTIC ANTIBIOTIC COMBINATIONS FOR COLISTIN-RESISTANT KLEBSIELLA PNEUMONIAE
    Kadar, Bela
    Kocsis, Bela
    Toth, Akos
    Damjanova, Ivelina
    Szasz, Mate
    Kristof, Katalin
    Nagy, Karoly
    Szabo, Dora
    [J]. ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2013, 60 (02) : 201 - 209